Transcatheter aortic valve replacement in aortic regurgitation: The U.S. experience-Reference-Cited by-同舟云学术

Transcatheter aortic valve replacement in aortic regurgitation: The U.S. experience

Published:2020-11-09 Issue:1 Volume:98 Page:
ISSN:1522-1946
Container-title:Catheterization and Cardiovascular Interventions
language:en
Short-container-title:Catheter Cardiovasc Interv

Author:

Arora Shilpkumar¹,Lahewala Sopan²^ORCID,Zuzek Zachary¹,Thakkar Samarthkumar³,Jani Chinmay⁴,Jaswaney Rahul¹,Singh Aanandita⁵,Bhyan Poonam⁶,Arora Nirav⁷,Main Anthony¹,Osman Mohammed Najeeb¹,Hoit Brian D.¹,Attizzani Guilherme F.¹,Panaich Sidakpal S.⁸^ORCID

Affiliation:

1. Harrington Heart and Vascular Institute, University Hospital Cleveland Medical Center Case Western Reserve University Cleveland Ohio

2. Department of Medicine Saint Francis Hospital and Medical Center Hartford Connecticut

3. Department of Medicine Rochester General Hospital Rochester New York

4. Department of Medicine Mount Auburn Hospital‐Harvard Medical School Cambridge Massachusetts

5. Department of Medicine Sri Guru Ram Das Institute of Medical Sciences & Research Amritsar Punjab India

6. Department of Medicine Cape Fear Valley Medical Center North Carolina

7. Department of Computer Science Lamar University Beaumont Texas

8. Department of Cardiology University of Iowa Hospitals & Clinics Iowa city Iowa

Publisher

Wiley

Subject

Cardiology and Cardiovascular Medicine,Radiology, Nuclear Medicine and imaging,General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/ccd.29379

Reference28 articles.

1. 5-year outcomes of transcatheter aortic valve replacement compared with standard treatment for patients with inoperable aortic stenosis (PARTNER 1): a randomised controlled trial

2. Transcatheter versus Surgical Aortic-Valve Replacement in High-Risk Patients

3. Transcatheter or Surgical Aortic-Valve Replacement in Intermediate-Risk Patients

4. Surgical or Transcatheter Aortic-Valve Replacement in Intermediate-Risk Patients

5. TAVI for pure native aortic regurgitation: are we there yet?;Arias EA;Interv Cardiol,2019

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Mortality and resource utilization in surgical versus transcatheter repeat mitral valve replacement: A national analysis;PLOS ONE;2024-05-23

2. Transfemoral transcatheter aortic valve replacement with VitaFlowTM valve for pure native aortic regurgitation in patients with high surgical risk: Rationale and design of a prospective, multicenter, and randomized SEASON-AR trial;American Heart Journal;2024-05

3. Application of echocardiography in transcatheter aortic valve replacement in patients with severe aortic regurgitation and correlation analysis of postprocedural complications;Echocardiography;2024-03

4. Impact of Transcatheter Aortic Valve Replacement on Cardiac Reverse Remodeling and Prognosis in Mixed Aortic Valve Disease;Journal of the American Heart Association;2024-02-20

5. Predictors for new-onset conduction block in patients with pure native aortic regurgitation after transcatheter aortic valve replacement with a new-generation self-expanding valve (VitaFlow Liberty™): a retrospective cohort study;BMC Cardiovascular Disorders;2024-01-28